Novartis AG News Headlines

NVS 
$99.04
*  
0.02
0.02%
Get NVS Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading NVS now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Today's Market: Stocks Rising On Mergers And Acquisitions Activity, Rumors In The Market
2/26/2015 9:16:00 AM - Seeking Alpha


Exchange-traded funds that hold big pharma
2/26/2015 9:05:00 AM - Market Realist


Pharmacyclics (PCYC) Jumps 16.9% on Takeover Rumors - Analyst Blog
2/26/2015 9:00:00 AM - Zacks.com


Why Pharmacyclics, Inc. Soared Higher Today
2/25/2015 3:07:27 PM - Motley Fool


Pharmacyclics Mulls Sale of Company -Bloomberg
2/25/2015 1:21:00 PM - Dow Jones Business News


Looking Ahead at Exelixis, Inc.
2/25/2015 12:30:00 PM - Motley Fool


The Swiss Stock Market Dipped Following Recent Recovery
2/25/2015 12:25:00 PM - RTT News


5 Things Biogen Idec Inc's Management Wants You to Know
2/25/2015 7:59:02 AM - Motley Fool


Big pharma diversifies business to mitigate patent risk
2/24/2015 5:06:00 PM - Market Realist


Novartis' Farydak Approved for Multiple Myeloma with Warning - Analyst Blog
2/24/2015 4:13:00 PM - Zacks.com


The Swiss Stock Market Finished Modestly Higher Thanks To U.S. Support
2/24/2015 12:29:00 PM - RTT News


Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for February 25, 2015
2/24/2015 9:00:03 AM - NASDAQ.com News


Perrigo Company (PRGO) Ex-Dividend Date Scheduled for February 25, 2015
2/24/2015 9:00:03 AM - NASDAQ.com News


Novartis Says FDA Has Approved Use of Farydak to Treat Multiple Myeloma
2/24/2015 4:06:00 AM - Dow Jones Business News


European Stocks Seen Flat As Investors Await Greek Reform Proposals
2/24/2015 2:09:00 AM - RTT News


Hot Income Stocks: Who's Growing Dividends The Fastest?
2/23/2015 4:49:00 PM - Investor's Business Daily


Novartis Receives FDA Approval Of Farydak For Treatment Of Multiple Myeloma
2/23/2015 4:40:00 PM - RTT News


Heptares Takes Sosei Out Of Its Comfort Zone
2/23/2015 3:37:00 PM - Seeking Alpha


Press Release: FDA Approves Farydak for Treatment of Multiple Myeloma
2/23/2015 3:20:00 PM - Dow Jones Business News


Why Spectrum Pharmaceuticals, Inc.'s Shares Collapsed
2/23/2015 1:56:44 PM - Motley Fool


The Swiss Stock Market Climbed On Strength Of Defensive Heavyweights
2/23/2015 12:28:00 PM - RTT News


Big pharma invests big money in research and development
2/23/2015 11:06:00 AM - Market Realist


Big pharma invests big money in research and development
2/20/2015 5:30:00 PM - Market Realist


Immuno-Oncology Promises Continued Wealth And Health: LifeTech Capital's Stephen Dunn
2/20/2015 12:11:00 PM - Seeking Alpha


Why Momenta Pharmaceuticals, Inc. Jumped Higher Today
2/19/2015 4:57:08 PM - Motley Fool